Navigating the Course of Dermatofibroma: Diagnosis and Outcomes

Looking for the dermatofibroma dermoscopy? View our catalog to find the right dermatoscope cost ; dermoscopy actinic keratosis, and more.

Dermatofibromas, small, slowly developing dark nodules, are more prevalent among middle-aged individuals and appear to have a slight female predominance. These benign skin growths can present in various forms, each with distinct clinical characteristics.

Diagnosis

The identification of a typical fibrous histiocytoma is generally uncomplicated, characterized by a small size of under 1 cm, a color spectrum from pink to tan to red, and a mildly rough or acanthotic texture. These nodules are usually painless, not inflamed, and occur singly. A positive dimpling sign, indicative of epidermal attachment to the nodule, is a common feature.

Management Strategies

Dermatofibromas are often asymptomatic, aside from their visible presence. They are typically left untreated unless they cause significant cosmetic concern, are located in an inconvenient area, or their diagnosis is not clear without a biopsy, particularly when there is a possibility of the nodule being a skin carcinoma or melanoma.

Excision may be recommended for atypical or suspicious nodules to exclude malignancy. However, it is important to consider that the resulting scar might be more noticeable than the original dermatofibroma. If the nodule is unusually large, rapidly growing, irregular, or located in an uncommon site, excision, including the subcutaneous tissue, is advised for histopathological assessment.

Recurrence and Risk of Malignancy

After local excision, the recurrence rate for certain subtypes of dermatofibroma is relatively high, at around 20 percent. All excised tumors should be biopsied, as some skin growths diagnosed preoperatively as benign have been found to harbor skin cancer upon pathological examination.

To ensure complete removal and reduce recurrence, elliptical excision or punch biopsy that includes subcutaneous tissue is preferred over cryotherapy, laser treatment, or shave excision, which carry a higher risk of incomplete removal. Intralesional corticosteroid injections have been attempted with variable success.

Prognosis

Although dermatofibromas are generally benign, rare instances of cellular dermatofibromas metastasizing exist. Thus, any recurring lesion should be monitored closely to rule out malignancy. Similarly, lesions with atypical histologic features require careful follow-up.

Spontaneous regression of dermatofibromas is rare, and without complete excision, most persist indefinitely. The cellular variant may grow over time. Shaving the area over the tumor could lead to repeated injury and microtrauma, potentially affecting the lesion.

Complications and Special Considerations

While dermatofibromas are typically uncomplicated, certain complications can arise, such as microtrauma due to their protruding nature. Additionally, eruptive dermatofibromas, where dozens appear over a few months, are seen in immunosuppressed patients or those with autoimmune diseases, possibly linked to immunosuppressive drugs or conditions.

Certain variants, like atrophic dermatofibromas, may resemble more aggressive conditions such as dermatofibrosarcoma or melanoma, necessitating careful diagnosis and management.

In summary, while dermatofibromas are generally benign and may be left untreated, careful consideration is needed for atypical or suspicious lesions. Complete excision, when necessary, should be performed with attention to minimizing recurrence and the risk of leaving a more noticeable scar. Regular follow-up is essential to monitor for recurrence and to rule out malignancy.